Core Insights - Newton Golf Company has announced an At-the-Market (ATM) equity offering agreement to raise up to US$10 million in common stock, with Kingswood U.S. acting as the sales agent [1][3] - The capital raised will support production, retail and tour channel expansion, and ongoing innovation in golf equipment, particularly in shafts and putters [1][3][4] Company Overview - Newton Golf is a technology-driven golf equipment company specializing in high-performance shafts and putters, with recent product releases including the Newton Fast Motion shaft line designed to enhance swing speed while maintaining control [2][8] - The company has expanded its product line from putters to performance shafts, including the Newton Motion and Fast Motion families, which are engineered for higher swing speed and stability [3][8] Financial Strategy - Under the ATM program, Newton Golf can sell newly issued shares at prevailing market prices, allowing for efficient access to growth capital while aligning with market liquidity [3] - The capital raised is intended to support retail sell-through, fitter network expansion, and tour adoption, indicating a focus on increasing market presence and sales [3][5] Market Engagement - Newton Golf has showcased its new shafts and putters at major industry events, enhancing engagement with fitters and retailers, which is expected to lead to faster inventory turns and wider distribution [4] - The company is gaining traction in the market, supported by growing media coverage and ongoing product releases [4][5]

Company Overview - MiMedia Holdings Inc. is participating in the ArcStone-Kingswood Growth Summit 2025 in Toronto, scheduled for September 18, 2025, where CEO Chris Giordano will present the company's recent business and future growth strategy [1][2] - MiMedia provides an AI and data-powered consumer cloud platform that secures personal media, allowing seamless access across devices and operating systems, with features that enhance content re-engagement [6] Event Details - The ArcStone-Kingswood Growth Summit will feature over 20 high-growth companies and a curated group of institutional and retail investors, focusing on strategic networking and insight-sharing [2] - The event will include keynote presentations, expert-led panel discussions, and focused one-on-one meetings aimed at connecting investors with compelling opportunities [2] Strategic Partnerships - ArcStone Securities and Investments Corp. specializes in providing bespoke financial solutions to mid-market companies, particularly in cross-border transactions between Canada and the United States [4] - Kingswood US, part of the Kingswood Group, offers a comprehensive suite of investment banking, wealth management, and equity research solutions [5]

Safe Supply Streaming Co Ltd. to Attend the ArcStone-Kingswood Growth Summit 2025 in TorontoSeptember 16, 2025 9:14 AM EDT | Source: ArcStone US Corp.Toronto, Ontario--(Newsfile Corp. - September 16, 2025) - Safe Supply Streaming Co Ltd. (CSE: SPLY) (OTCQB: SSPLF) (FSE: QM4) ("Safe Supply" or the "Company") is pleased to announce its participation in the upcoming ArcStone-Kingswood Growth Summit in Toronto, taking place on September 18, 2025 at the St. Regis Toronto. Geoff Benic, Chief Executi ...

Company Overview - Lobe Sciences Ltd. is a clinical stage biopharmaceutical company focused on developing novel therapies for rare neurological and hematological conditions [7] - The company operates through two subsidiaries and emphasizes its differentiated pipeline characterized by intellectual property, clinical momentum, and a strategic focus on high-value, underserved markets [7] Upcoming Event - Lobe Sciences will participate in the ArcStone-Kingswood Growth Summit in Toronto on September 18, 2025, where CEO Dr. Frederick D Sancilio will present the company's recent milestones and future growth strategy [2] - The summit will host over 20 companies and provide opportunities for targeted 1-on-1 meetings, panel discussions, and networking among industry professionals [3] Strategic Focus - Cynaptec Pharmaceuticals, Inc., a subsidiary owned 64% by Lobe Sciences, is advancing a patented new chemical entity targeting Chronic Cluster Headache, an orphan indication [8] - Altemia, Inc. is addressing sickle cell disease with two complementary assets: a medical food in early-stage distribution and a patent-pending therapeutic candidate designed to treat the underlying pathology of the disease [8]

Core Insights - SuperQ Quantum Computing Inc. is participating in the ArcStone-Kingswood Growth Summit on September 18, 2025, in Toronto, where CEO Dr. Muhammad Khan will present the company's recent milestones and growth strategy [1][2] Company Overview - SuperQ Quantum Computing Inc. is a leader in commercial quantum and supercomputing, focusing on delivering significant ROI for global organizations through advanced computational power [5][6] - The company's flagship Super™ platform aims to make quantum computing intuitive and accessible, targeting sectors such as finance, healthcare, logistics, and defense [6] Event Details - The ArcStone-Kingswood Growth Summit will feature over 20 high-growth companies and a curated group of institutional and retail investors, facilitating strategic networking and insight-sharing [2] - The event will include keynote presentations, expert-led panel discussions, and focused one-on-one meetings to connect investors with compelling opportunities [2] Strategic Partnerships - ArcStone Securities and Investments Corp. is a diversified financial services firm that specializes in bespoke solutions for mid-market companies, particularly in cross-border transactions between Canada and the U.S. [4] - Kingswood US, part of the Kingswood Group, provides comprehensive investment banking, wealth management, and equity research solutions [4]

Core Insights - SuperQ Quantum Computing Inc. has engaged ArcStone Canada Inc. for comprehensive capital markets advisory services aimed at enhancing visibility and shareholder value through quantum and supercomputing innovation [1][2][4] - The partnership is expected to support SuperQ's growth strategy by providing institutional coverage and U.S. market access, aligning its technological advancements with strategic capital market expertise [3][4] Company Overview - SuperQ Quantum Computing Inc. is positioned as a leader in quantum and supercomputing, focusing on delivering transformative ROI for global organizations [5][6] - The flagship Super™ platform aims to make advanced computational power accessible, targeting sectors such as finance, healthcare, logistics, and defense [6] Advisory Firm Overview - ArcStone Canada Inc. is a capital markets advisory firm that provides a range of services including investment banking, equity research, and growth conferences, with a strong presence in North America [8]

Industry Overview - The oral stimulant pouch market is identified as a rapidly emerging, multi-billion dollar sector within the health and wellness consumer industry [1] - The market is characterized by high growth potential, driven by increasing consumer demand for innovative health products [1] Company Focus: Mangoceuticals, Inc. - Mangoceuticals, Inc. is highlighted as a key player in the oral stimulant pouch market, strategically positioned to leverage its proprietary science and intellectual property [2] - The company has acquired exclusive North American rights to Diabetinol, a clinically validated supplement for prediabetes and Type II diabetes, which supports future product development in oral pouches [2][9] - Mangoceuticals has appointed Tim Corkum, a veteran with 20 years of experience at Philip Morris International, as President of the Pouch Division to lead its expansion efforts [3] Market Position and Strategy - Mangoceuticals is noted as one of the few publicly listed companies entering the oral stimulant category at scale, with a strong IP portfolio and a tight float [4] - The company is well-positioned to execute an aggressive, asset-light roll-up strategy in the rapidly expanding sector, capitalizing on significant market opportunities [4]

Core Insights - ArcStone Securities and Investments Corp. serves as the exclusive financial advisor to Mangoceuticals Inc. in its acquisition of Smokeless Technology Corp., marking Mangoceuticals' entry into the high-growth oral stimulant pouch sector [1][2][3] - The acquisition enhances Mangoceuticals' capabilities in the consumer-packaged goods sector, targeting various demographics including athletes and Gen Z consumers seeking healthier alternatives [3][6] - The transaction is expected to position Mangoceuticals as a leader in the next-generation health and wellness delivery market, leveraging Smokeless Tech's intellectual property and formulations [6][7] Company Overview - Mangoceuticals Inc. is focused on launching high-impact pouches and aims to disrupt traditional wellness delivery methods with "better-for-you" energy solutions [6][7] - The company is set to benefit from the expertise of Tim Corkum, a veteran from Philip Morris International, who will lead the new Pouch Division [4][5] - The acquisition positions Mangoceuticals as one of the few public companies in the functional wellness and oral delivery market, appealing to both institutional and retail investors [8] Strategic Implications - The deal signifies a transformational step for Mangoceuticals, aligning with the trend towards on-the-go, clinically informed wellness solutions [7] - ArcStone's role underscores its expertise in cross-border M&A, particularly in the health and wellness sectors, enhancing its reputation in the financial advisory landscape [3][9] - The combined entity will focus on sourcing disruptive ingredients and proprietary formulations, aiming to lead in the wellness delivery category [6][7]

Core Viewpoint - Mangoceuticals Inc. has entered into an Intellectual Property Purchase Agreement to acquire Smokeless Technology Corp., marking a strategic expansion into the oral pouch delivery market, which is rapidly growing in the consumer wellness and alternative nicotine sectors [1][2]. Company Overview - Mangoceuticals focuses on developing, marketing, and selling health and wellness products through a secure telemedicine platform under the brands MangoRx and PeachesRx [1][10]. - The company aims to integrate Smokeless Tech's stimulant formulations with pharmaceutical ingredients to enhance its product offerings [2][5]. Market Insights - The U.S. nicotine pouch market reached $3.13 billion in 2024, with Zyn as the category leader at over $1.6 billion in sales [3]. - The global oral pouch market is projected to exceed $37.34 billion by 2032, indicating significant growth potential for functional wellness pouches [3]. Strategic Growth Plans - The acquisition is expected to unlock new growth phases for Mangoceuticals, aligning with the company's mission to develop health and wellness products with executable business models [4]. - The company plans to leverage its established distribution network and upcoming product launches, such as Diabetinol, to enhance its market position [6]. Leadership Enhancement - Tim Corkum, a veteran in Consumer Packaged Goods, has joined the management team to drive the development of new non-pharmaceutical and nutraceutical products [4][5][8]. - Corkum's experience includes leadership roles at JUUL Labs Canada and Philip Morris International, focusing on smoke-free initiatives and business development [8][9].

Toronto, Ontario--(Newsfile Corp. - April 14, 2025) -  ArcStone Canada Inc., a subsidiary of ArcStone Securities and Investments Corp. ("ArcStone"), a premier cross-border financial services firm based in Toronto, New York City, and Dallas, proudly announces the release of its report on Revolve Renewable Power Corp. (TSXV: REVV) (OTCQB: REVVF), an emerging leader in the renewable energy sector.ArcStone's in-depth analysis highlights Revolve's strategic focus on high-growth markets, robust project pipeline, ...